Subsyndromal Symptoms in Bipolar Disorder: A Comparison of Standard and Low Serum Levels of Lithium

Archives of General Psychiatry

Volumn 49, Issue 5, 1992, Pages 371-376

  Keller, Martin B ^a   Lavori, Philip W ^a   Kane, John M ^b   Gelenberg, Alan J ^c   Rosenbaum, Jerrold F ^d   Walzer, Elizabeth A ^d   Baker, Lori A ^a  

^a BROWN UNIVERSITY   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; HYPOMANIA; LITHIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; RATING SCALE; RELAPSE; REMISSION; SYMPTOM; SYNDROME DELINEATION;

ADOLESCENT; ADULT; AGED; BIPOLAR DISORDER; DOUBLE-BLIND METHOD; FEMALE; HUMAN; LITHIUM; MALE; MIDDLE AGE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026717180     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1992.01820050035005     Document Type: Article

References (28)

1. Prien RF, Caffey EM, Klett JC. Factors associated with treatment success in lithium carbonate prophylaxis. Arch Gen Psychiatry. 1974;31: 189–192.
2. Schou M. Lithium as a prophylactic agent in unipolar affective illness. Arch Gen Psychiatry. 1979;36: 849–851.
3. Coppen A, Noguera R, Bailey J, Burns BH, Swani MS, Hare EH, Gardner R, Maggs R. Prophylactic lithium in affective disorders. Lancet. 1971;2: 275–279.
4. Cohen I, Bunney WE, Cole JO, Fieve RR, Gershon S, Prien RF. The current status of lithium therapy: report of the APA task force. Am J Psychiatry. 1975;133: 997–1001.
5. Consensus Development Panel. NIMH/NIH Consensus Development Conference statement: mood disorders: pharmacologic prevention of recurrences. Am J Psychiatry. 1985;142: 469–476.
6. Gelenberg AJ, Wojcik JD, Falk WE, Coggins CH, Brotman AW, Rosenbaum JF, LaBrie RA, Klerman BJ. Effects of lithium on the kidney. Acta Psychiatr Scand. 1987;75: 29–34.
7. Goodnick PJ, Fieve RR, Schlegel A, Kaufman K. Lithium level and inter-episode symptoms in affective disorder. Acta Psychiatr Scand. 1987;75: 601–603.
8. Mander AJ. Use of lithium and early relapse in manic-depressive illness. Acta Psychiatr Scand. 1988;78: 198–200.
9. Mander AJ. Clinical prediction of outcome and lithium response in bipolar affective disorder. J Affective Disord. 1986;11: 35–41.
10. Miklowitz DJ, Goldstein MJ, Nuechterlein KH, Snyder KS, Doane JA. Expressed emotion, affective style, lithium compliance, and relapse in recent onset mania. Psychopharmacol Bull. 1986;22: 628–632.
11. O'Connell RA, Mayo JA, Eng LK, Jones JS, Gabel RH. Social support and long-term lithium outcome. BrJ Psychiatry. 1985;147: 272–275.
12. Prien RF, Kupfer DJ, Mansky PA, Small JG, Uason VB, Voss CB, Johnson WE. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Arch Gen Psychiatry. 1984;41: 1096–1104.
13. Goodnick PJ, Fieve RR, Schlegel A, Kaufman K. Inter-episode major and subclinical symptoms in affective disorder. Acta Psychiatr Scand. 1987;75: 597–600.
14. Lieberman PB, Strauss JS. The recurrence of mania: environmental factors and medical treatment. Am J Psychiatry. 1984;141: 77–80.
15. Gelenberg AJ, Kane JM, Keller MB, Lavori P, Rosenbaum JF, Cole K, Lavelle J. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl I Med. 1989;321: 1489–1493.
16. Frank E, Prien R, Jarrett RB, Keller MB, Kupfer DJ, Lavori P, Rush AJ, Weissman MM. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: response, remission, recovery, relapse and recurrence. Arch Gen Psychiatry. 1991;48:851855.
17. Prien RF, Carpenter LL, Kupfer DJ. The definition and operational criteria for treatment outcome of unipolar depression: a review of the current research literature. Arch Gen Psychiatry. In press.
18. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing ratel reliability. Psychol Bull. 1979;86: 420–428.
19. Keller MB, Lavori PW, Friedman B, Nielsen E, Endicott J McDonald-Scott P, Andreasen NC. The LIFE: a comprehensive methoc for assessing outcome in prospective longitudinal studies. Arch Ger Psychiatry. 1987;44: 540–548.
20. Angst J. The course of affective disorders, II: typology of bipola manic-depressive illness. Arch Psychiatry Neurol Sci. 1978;226: 65–73.
21. Perris C. The course of depressive psychoses. Acta Psychiat Scand. 1968;44: 238–248.
22. Winokur G, Clayton P, Reich T. Manic-Depressive Illness. S Louis, Mo: Mosby—Year Book; 1969.
23. Bastruup PC, Poulsen JC, Schou M. Prophylactic lithium: double blind discontinuation in manic-depressives and recurrent depressivi disorders. Lancet. 1970;2: 226–230.
24. Cundall RL, Brooks PW, Murray LG. A controlled evaluation o lithium prophylaxis in affective disorders. Psychol Med. 1972;2: 308–311
25. Stallone F, Shelly E, Mendlewicz J, Fieve RR. The use of lithiur in affective disorders, III: a double-blind study of prophylaxis in bipc lar illness. Am J Psychiatry. 1973;130: 1006–1010.
26. Prien RF, Caffey EM, Klett CJ. Prophylactic efficacy of lithium cai bonate in manic-depressive illness. Arch Gen Psychiatry. 1973;28: 337–341.
27. Prien RF, Klett CH, Caffey EM. Lithium carbonate and imipramin in prevention of affective episodes. Arch Gen Psychiatry. 1973;29:42(425.
28. Quitkin RM, Rabkin JG, Prien RF. Bipolar disorder: are ther manic-prone and depressive-prone forms? J Clin Psychopharmaco 1986;6: 167–172.